TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10405740

Group type: EXPERIMENTAL
Intervention: Core-needle biopsy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Surgical biopsy
Number of subjects: 132
Study: 7789344

Group type: COMPARATOR
Intervention: Psychosocial interventions
Number of subjects: 62
Study: 2193304

Group type: EXPERIMENTAL
Intervention: Corticosteroid group (betamethasone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study: 365670

Group type: EXPERIMENTAL
Intervention: Simethicone solution before peroral endoscopy
Number of subjects: 0
Study: 31520445

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser (EL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: gain-switched 311-nm titanium:sapphire laser (TSL)
Number of subjects: 10
Study: 31590034

Group type: EXPERIMENTAL
Intervention: High intensity exercise programme (n=39)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Low intensity exercise programme (n=38)
Number of subjects: 77
Study: 28880867

Group type: EXPERIMENTAL
Intervention: THU-decitabine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 25904273

Group type: EXPERIMENTAL
Intervention: 3 K-wires and a volar semi-circular cast for the first 3 weeks followed by a removable splint for a further 3 weeks (Group I)
Number of subjects: 92

Group type: COMPARATOR
Intervention: 2 K-wires and a below-elbow circular cast for 6 weeks postoperatively (Group II)
Number of subjects: 92
Study: 24239210

Group type: EXPERIMENTAL
Intervention: Sequential treatment (FEC-75 followed by paclitaxel plus trastuzumab)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Concurrent treatment (paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Sequential treatment
Number of subjects: 282

Group type: COMPARATOR
Intervention: Concurrent treatment
Number of subjects: 282
Study: 21068353

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (200,000 IU retinyl palmitate plus 15 mg Zn/d for 8 weeks)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation
Number of subjects: 154
Study: 18475165

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 208
Study: 16472039

Group type: EXPERIMENTAL
Intervention: CHANGE intervention (supplemental to usual care)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual-care-only group
Number of subjects: 250
Study: 14662280

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Air
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Control group (no antiemetic interventions)
Number of subjects: 5000
Study: 11195960

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Estradiol-medroxyprogesterone
Number of subjects: 106
Study: 9068458

Group type: EXPERIMENTAL
Intervention: Uncovered Wallstent
Number of subjects: 82

Group type: COMPARATOR
Intervention: Knitted nitinol stent
Number of subjects: 82
Study: 7983954

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 2690739

Group type: EXPERIMENTAL
Intervention: Preterm formula
Number of subjects: 502

Group type: COMPARATOR
Intervention: Donor breast milk
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Mother's expressed milk with banked milk supplement
Number of subjects: 502

Group type: COMPARATOR
Intervention: Donor breast milk in infants with fetal growth retardation
Number of subjects: 502
Study: 1131298

Group type: EXPERIMENTAL
Intervention: Freshly extracted juice of 50 g of garlic
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Freshly extracted juice of 50 g of onion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ether-extracted essential oils of garlic
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ether-extracted essential oils of onion
Number of subjects: 10
Study: 30985450

Group type: EXPERIMENTAL
Intervention: In-hospital nighttime intensivist staffing
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard daytime intensivist model
Number of subjects: 33
Study: 27586512

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and analgesics for 72 hours after abdominal operations
Number of subjects: 113

Group type: COMPARATOR
Intervention: Only analgesics
Number of subjects: 113
Study: 26884660

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal/iliohypogastric nerve block (IINB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Traditional Schulte-Steinberg IINB
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous anesthesia (ketamine-propofol) only (Control)
Number of subjects: 90
Study: 23406536

Group type: EXPERIMENTAL
Intervention: Deflazacort (1 mg/kg/day in month one, 1 mg/kg every 2nd day during months two to six)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: COMPARATOR
Intervention: Natural course (no intervention)
Number of subjects: 25
Study: 21931864

Group type: EXPERIMENTAL
Intervention: Intraduodenal pea protein administration (250 mg/kg bodyweight in 0.4 ml/kg bodyweight of water)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intraduodenal pea protein administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (0.4 ml/kg bodyweight of water)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral pea protein administration
Number of subjects: 20
Study: 20029895

Group type: EXPERIMENTAL
Intervention: Pattern-mixture zero-inflated model with compound Poisson random effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quasi-likelihood approach
Number of subjects: 0
Study: 17727530

Group type: EXPERIMENTAL
Intervention: Active-type questions
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Reflective-type questions
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Matched learners
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Mismatched learners
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Construct table format
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Table provided format
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Course ratings
Number of subjects: 89
Study: 15272628

Group type: EXPERIMENTAL
Intervention: Intravenous cytoflavin dropper injections once daily for 10 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5% glucose solution (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous cytoflavin
Number of subjects: 60
Study: 11232022

Group type: EXPERIMENTAL
Intervention: Transdermal administration of 100 microgram/day estradiol (E(2)) for 2 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (P) for 2 days
Number of subjects: 11
Study: 8829399

Group type: EXPERIMENTAL
Intervention: Psychological debriefing at two weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no psychological debriefing)
Number of subjects: 0
Study: 1425532

Group type: EXPERIMENTAL
Intervention: Intensive treatment (individual counselling)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intensive treatment (group therapy)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional treatment (school health care setting)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Successful weight losers
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Predictors of success
Number of subjects: 48
Study: 4011126

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate (500 mg, 3 times daily for 3 months)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (3 capsules daily for 3 months)
Number of subjects: 37
Study: 31411793

Group type: COMPARATOR
Intervention: Concomitant therapy (amoxicillin 1 g, clarithromycin 500 mg, metronidazole 500 mg, and lansoprazole 30 mg twice/day for 14 days)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Tailored therapy (amoxicillin 1 g, clarithromycin 500 mg, and lansoprazole 30 mg twice/day for 14 days in point mutation-negative subjects; amoxicillin 1 g, metronidazole 500 mg, and lansoprazole 30 mg twice/day for 14 days in point mutation-positive subjects)
Number of subjects: 397
Study: 29866199

Group type: EXPERIMENTAL
Intervention: Prescription hydration plan (PHP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal ad libitum hydration habits (NHP)
Number of subjects: 15
Study: 26498173

Group type: COMPARATOR
Intervention: Noncontingent vouchers
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Contingent vouchers
Number of subjects: 338
Study: 24803153

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 40
Study: 22595362

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 2000 mg/day
Number of subjects: 409

Group type: COMPARATOR
Intervention: Lamotrigine (LTG) 200 mg/day
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Lamotrigine (LTG)
Number of subjects: 409
Study: 19398690

Group type: EXPERIMENTAL
Intervention: Electronic health record enhancement (smoking status icons, tobacco treatment reminders, Tobacco Smart Form)
Number of subjects: 132630

Group type: EXPERIMENTAL
Intervention: Electronic health record enhancement
Number of subjects: 132630

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 132630
Study: 17400393

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDCT)
Number of subjects: 2728
Study: 16312917

Group type: EXPERIMENTAL
Intervention: Acupuncture plus medicine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Medicine
Number of subjects: 75
Study: 11786563

Group type: EXPERIMENTAL
Intervention: Adenosine 5'‐triphosphate (ATP) infusion (10 intravenous, 30‐hour infusions every 2 to 4 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (no ATP)
Number of subjects: 58
Study: 9667340

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tracheal Tube (TT)
Number of subjects: 20
Study: 7662755

Group type: EXPERIMENTAL
Intervention: Nutritional evaluation upon admittance and after 7 days, measuring albumin and body weight/ideal weight ratio.
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Nutritional evaluation after 7 days for patients who continued hospitalization.
Number of subjects: 301

Group type: COMPARATOR
Intervention: Comparison of incidence of PEM based on age and type of department.
Number of subjects: 301
Study: 2113093

Group type: EXPERIMENTAL
Intervention: Rabbit antithymocyte globulin (polyclonal)
Number of subjects: 82

Group type: COMPARATOR
Intervention: OKT3 monoclonal antibody
Number of subjects: 82
Study: 380615

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Amylobarbitone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31287783

Group type: EXPERIMENTAL
Intervention: Health education and brief action and coping planning intervention (Experimental Group)
Number of subjects: 153
Study: 30295931

Group type: EXPERIMENTAL
Intervention: Lymphaticovenous anastomosis (LVA) surgery
Number of subjects: 27

Group type: COMPARATOR
Intervention: Compression garment therapy (CGT) after surgery
Number of subjects: 27
Study: 26842867

Group type: EXPERIMENTAL
Intervention: Capoeira progressive training program (10 weeks, 1 session per week, 90 minutes each)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Capoeira progressive training program
Number of subjects: 18
Study: 25879419

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-help materials on smoking cessation (Control)
Number of subjects: 0
Study: 23671894

Group type: EXPERIMENTAL
Intervention: PVA coated nasal packing
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-absorbable nasal packing
Number of subjects: 33
Study: 21480180

Group type: EXPERIMENTAL
Intervention: Coupled plasma filtration adsorption (CPFA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: High volume hemofiltration (HVHF)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CPFA
Number of subjects: 24

Group type: COMPARATOR
Intervention: HVHF
Number of subjects: 24
Study: 19944390

Group type: EXPERIMENTAL
Intervention: Extension tube
Number of subjects: 230

Group type: COMPARATOR
Intervention: No extension tube (Control)
Number of subjects: 230
Study: 17321484

Group type: EXPERIMENTAL
Intervention: Cold pressor (CP) stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mock CP trial
Number of subjects: 10
Study: 15565568

Group type: EXPERIMENTAL
Intervention: Leuprorelin (3.75 mg/mo subcutaneously), flutamide (750 mg/d orally), and tamoxifen (30 mg/d orally)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Tamoxifen alone (30 mg/d orally)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Leuprorelin, flutamide, and tamoxifen
Number of subjects: 376
Study: 11327062

Group type: EXPERIMENTAL
Intervention: Root planing and scaling
Number of subjects: 2

Group type: COMPARATOR
Intervention: Non-scaled sites
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Scaled sites
Number of subjects: 2
Study: 9012624

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 20
Study: 7943588

Group type: EXPERIMENTAL
Intervention: Handsewn anastomosis (Hs)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Stapled anastomosis (St)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both Hs and St
Number of subjects: 88
Study: 2905632

Group type: EXPERIMENTAL
Intervention: Neuroleptic therapy in schizophrenics with affective heredity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neuroleptic therapy in schizophrenics with schizophrenic heredity
Number of subjects: 0
Study: 31468547

Group type: EXPERIMENTAL
Intervention: Exposure, Relaxation, and Rescripting Therapy (ERRT)
Number of subjects: 75
Study: 27780669

Group type: EXPERIMENTAL
Intervention: PEACH intervention
Number of subjects: 95
Study: 25320361

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23904684

Group type: EXPERIMENTAL
Intervention: 1 lux light exposure prior to 90 lux light stimulus
Number of subjects: 14

Group type: COMPARATOR
Intervention: 90 lux light exposure prior to 90 lux light stimulus
Number of subjects: 14
Study: 20859562

Group type: EXPERIMENTAL
Intervention: Positioning stents
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no positioning stents)
Number of subjects: 48
Study: 18283233

Group type: EXPERIMENTAL
Intervention: Cefuroxime IV 750 mg tid for 10 days
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Cefuroxime IV 750 mg tid for 3 days followed by cefuroxime-axetil PO 500 mg bid for 7 days
Number of subjects: 142

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 142
Study: 16172214

Group type: EXPERIMENTAL
Intervention: High dietary intake of retinol
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: High intake of alpha‐tocopherol
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: High intake of gamma‐tocopherol
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Higher intakes of fruits
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Higher intake of vitamin C
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Higher intake of alpha‐tocopherol
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Higher intake of gamma‐tocopherol
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Higher intake of lycopene
Number of subjects: 29133
Study: 12853782

Group type: EXPERIMENTAL
Intervention: Electromagnetic lithotriptor (DLS)
Number of subjects: 694

Group type: COMPARATOR
Intervention: Electrohydraulic lithotriptor (MFL)
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 694
Study: 10378132

Group type: EXPERIMENTAL
Intervention: 1.5 g of azithromycin as a single dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: 500 mg of azithromycin once daily for 3 days
Number of subjects: 100
Study: 8905357

Group type: EXPERIMENTAL
Intervention: High-compliance balloon (HCB)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low-compliance balloon (LCB)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both HCB and LCB
Number of subjects: 25
Study: 2023142

Group type: EXPERIMENTAL
Intervention: Proportion of carbohydrate in a prepared meal and knowledge provided about its contents
Number of subjects: 56

Group type: COMPARATOR
Intervention: Laboratory-induced counter-regulatory eating
Number of subjects: 56
Study: 6630540

Group type: EXPERIMENTAL
Intervention: Self-administered cognitive therapy (RET)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Self-administered attention placebo condition (Logo-therapy)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 45
Study: 31277116

Group type: EXPERIMENTAL
Intervention: Warmed humidified CO2 insufflation (35°C, 95% relative humidity)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard CO2 insufflation
Number of subjects: 63
Study: 28189575

Group type: EXPERIMENTAL
Intervention: Active treatment (duloxetine or fluoxetine)
Number of subjects: 1462

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1462
Study: 27165955

Group type: EXPERIMENTAL
Intervention: Pharyngeal electric stimulation (PES)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 162
Study: 24933725

Group type: EXPERIMENTAL
Intervention: Cane Cognitive Mediator Scale (CCMS)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cane Cognitive Mediator Scale (CCMS) Subjective Norms subscale
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Psychosocial Impact of Assistive Devices Scale (PIADS) Adaptability subscale
Number of subjects: 53
Study: 21810729

Group type: COMPARATOR
Intervention: ara-C plus daunorubicin (DNR; 7+3)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: ara-C plus gemtuzumab ozogamicin (7+GO)
Number of subjects: 119
Study: 20957842

Group type: EXPERIMENTAL
Intervention: High frequency leg movements (HFLM)
Number of subjects: 37
Study: 17658025

Group type: EXPERIMENTAL
Intervention: BioEnterics Intragastric Balloon (BIB)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (BIB and Sham)
Number of subjects: 22
Study: 15747805

Group type: EXPERIMENTAL
Intervention: Computer-based treatment focusing on phonological and morphological structure of Dutch words
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Computer-based treatment
Number of subjects: 267
Study: 12125829

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention program (8 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38
Study: 10220188

Group type: EXPERIMENTAL
Intervention: Pneumatic foot compression combined with low-molecular-weight heparin for approximately 7 days after surgery
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (control group)
Number of subjects: 48
Study: 8570764

Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (5 mg) pretreatment
Number of subjects: 10
Study: 2353031

Group type: EXPERIMENTAL
Intervention: 75 mg/day aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 300 mg aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 300 mg/alternate day aspirin
Number of subjects: 0
Study: 377471

Group type: EXPERIMENTAL
Intervention: Fenbufen (600 mg per day for 4 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Aspirin (3.6 g per day for 4 weeks)
Number of subjects: 53
Study: 31267502

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 vaccine without booster
Number of subjects: 15459

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 vaccine with booster
Number of subjects: 15459
Study: 28574133

Group type: EXPERIMENTAL
Intervention: Femtosecond laser (FSL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Manual dissection
Number of subjects: 10
Study: 25885011

Group type: EXPERIMENTAL
Intervention: augmented treatment (stimulant + parent training + risperidone)
Number of subjects: 168

Group type: COMPARATOR
Intervention: basic treatment (stimulant + parent training + placebo)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: augmented treatment
Number of subjects: 168

Group type: COMPARATOR
Intervention: basic treatment
Number of subjects: 168
Study: 24111645

Group type: EXPERIMENTAL
Intervention: Icatibant (30 mg subcutaneously)
Number of subjects: 54
Study: 21792113

Group type: EXPERIMENTAL
Intervention: Lordotic allografts
Number of subjects: 122

Group type: COMPARATOR
Intervention: Parallel allografts
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both graft types (lordotic and parallel)
Number of subjects: 122
Study: 19422479

Group type: EXPERIMENTAL
Intervention: UDCA+VitE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UDCA+placebo (P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo (P)+placebo (P)
Number of subjects: 0
Study: 17156694

Group type: EXPERIMENTAL
Intervention: Intermittent diazepam prophylaxis (n = 68)
Number of subjects: 139

Group type: COMPARATOR
Intervention: No prophylaxis (n = 71)
Number of subjects: 139
Study: 15570782

Group type: EXPERIMENTAL
Intervention: Mobile lithotripter treatment (2000 shock waves at 2.5 bars of air pressure, frequency of 8-10Hz, 3 treatments at 2-week intervals)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Mobile lithotripter treatment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo treatment (clasp on elbow/heel to stop penetration of shock waves)
Number of subjects: 47
Study: 11022179

Group type: EXPERIMENTAL
Intervention: rhIFN-alpha
Number of subjects: 6

Group type: COMPARATOR
Intervention: saline
Number of subjects: 6